Samsung Biologics Secures 434 Billion KRW CMO Deal: What This Means for the Biopharmaceutical Market
AI 요약 정보
- Samsung Biologics wins 434.3 billion KRW CMO contract
- Contract runs through Dec. 31, 2031; client undisclosed
- Cumulative orders reach 22.3 billion USD since inception
